MSTX has broken the daily downtrend with a strong impulse. If it consolidates above the i'm expecting one more wave up. A strong breakdown on this can invalidate the setup.
The price of MSTX will be influenced more by soon to be released data on its Phase III study. According to a report from BIO (Clinical Development Success rates 2006-2015 pg 7), there's a 58% chance of Phase III data leading to an NDA and once an NDA is submitted a 85.3% chance of approval.